碳合金合剂Au (I) 抗癌剂通过双啡诱导的减少性消除
Sean T Gilpatrick1, Oluwatosin A Obisesan1, Sean Parkin1
1Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA. awuah@uky.edu.
Dalton transactions (Cambridge, England : 2003)
|August 20, 2024
概括
研究人员开发了具有显著抗癌性质的新型黄金复合物. 这些化合物通过诱导亡和破坏线粒体功能,有效地向癌细胞,提供潜在的新疗法策略.
科学领域:
- 无机化学 无机化学
- 药用化学 医学化学
- 材料科学 材料科学 材料科学
背景情况:
- 开发用于癌症治疗的新型黄金复合物是一个活跃的研究领域.
- 现有的黄金 (I) 和黄金 (III) 复合体显示出前景,但需要进一步的结构优化,以提高效率和稳定性.
- 循环金属金复合体为药物设计提供独特的结构图案.
研究的目的:
- 合成和描述一种新型的非对称黄金复合物.
- 为了研究这些新型黄金复合物的抗癌活性.
- 阐明这些复杂物在癌细胞中的作用机制.
主要方法:
- 通过使用循环金属化Au(III) 前体和双素,通过Au(III) 介导的C-P键形成合成金I) 复合物.
- 使用NMR (1H, 13C, 31P),质谱学,X射线晶体学,HPLC和元素分析进行了表征.
- 对一组癌细胞系的抗癌活性的评估以及涉及亡诱导,ROS生成和线粒体功能评估的机制研究.
主要成果:
- 成功合成了一种具有C-P合的新型非对称黄金 (I) 复合体.
- 合成的复合物在各种癌症细胞系中表现出有前途的抗癌活性.
- 机械研究表明,这些复合物诱导了亡,产生了线粒体的活性氧物种 (ROS),并改变了线粒体的呼吸.
结论:
- 已经开发出了一种新的Au(I) 复合物的结构类别,显示出显著的抗癌潜力.
- 这些复合物代表了开发新的基于黄金的抗癌剂的有希望的途径.
- 这些发现表明,这些复合物的潜在实用性超出了癌症治疗范围.
相关概念视频
Reduction of Alkynes to cis-Alkenes: Catalytic Hydrogenation
7.7K
Introduction
Like alkenes, alkynes can be reduced to alkanes in the presence of transition metal catalysts such as Pt, Pd, or Ni. The reaction involves two sequential syn additions of hydrogen via a cis-alkene intermediate.
Like alkenes, alkynes can be reduced to alkanes in the presence of transition metal catalysts such as Pt, Pd, or Ni. The reaction involves two sequential syn additions of hydrogen via a cis-alkene intermediate.
7.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Phase II Reactions: Miscellaneous Conjugation Reactions
48
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
48
Aldehydes and Ketones to Alkenes: Wittig Reaction Mechanism
3.4K
The Wittig reaction, which converts aldehydes or ketones to alkenes using phosphorus ylides, proceeds through a nucleophilic addition‒elimination process.
The reaction begins with the nucleophilic addition between a phosphorus ylide and the carbonyl compound. Due to its carbanionic character, phosphorus ylide acts as a strong nucleophile and attacks the electrophilic carbonyl group. This generates a charge-separated dipolar intermediate called betaine. The negatively charged oxygen atom and...
The reaction begins with the nucleophilic addition between a phosphorus ylide and the carbonyl compound. Due to its carbanionic character, phosphorus ylide acts as a strong nucleophile and attacks the electrophilic carbonyl group. This generates a charge-separated dipolar intermediate called betaine. The negatively charged oxygen atom and...
3.4K
Phase I Reactions: Reductive Reactions
187
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
187
Preparation of Amines: Reductive Amination of Aldehydes and Ketones
2.7K
Carbonyl compounds and primary amines undergo reductive amination first to produce imines, followed by secondary amines in the same reaction mixture, using selective reducing agents like sodium cyanoborohydride or sodium triacetoxyborohydride. Reductive amination produces different degrees of substitution of amines depending on the starting amine substrate.
2.7K


![[DPEPhosbcpCu]PF6: A General and Broadly Applicable Copper-Based Photoredox Catalyst](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59739.jpg&w=3840&q=50)